OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Immunopathology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Complement & disease: out of the shadow into the spotlight	132
Harnessing the n+1 dimensions of single-cell omics data for the prediction and prevention of human diseases	111
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	107
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	106
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	106
Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases	93
Monocyte dysregulation: consequences for hepatic infections	91
Fine mapping with epigenetic information and 3D structure	86
Th17 cells in the liver: balancing autoimmunity and pathogen defense	71
The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system	68
Adaptive immunity, chronic inflammation and the clock	66
Clonal hematopoiesis and vascular disease	52
CAF-immune cell crosstalk and its impact in immunotherapy	51
Learning cell identity in immunology, neuroscience, and cancer	49
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	47
Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target	43
Microchimerism and pregnancy complications with placental dysfunction	42
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	41
Circadian rhythms in adaptive immunity and vaccination	41
Causes and costs of global COVID-19 vaccine inequity	40
Systemic innate myeloid responses to acute ischaemic and haemorrhagic stroke	38
The eosinophil and its role in physiology and disease: news and views	38
Proteomics to study cancer immunity and improve treatment	38
Vascular galectins in tumor angiogenesis and cancer immunity	38
Tumor microenvironment antigens	37

MAIT cells in liver inflammation and fibrosis	35
Halting targeted and collateral damage to red blood cells by the complement system	35
Revisiting transplant immunology through the lens of single-cell technologies	35
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	35
Neuroimmune interactions in health and disease	33
Microbiota-derived metabolites in inflammatory bowel disease	33
Chronoimmunology: from preclinical assessments to clinical applications	33
Role of polyamines in intestinal mucosal barrier function	32
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy	32
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy	32
Advances in manufacturing chimeric antigen receptor immune cell therapies	31
The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies	31
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	31
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	30
The overlooked bacterial pandemic	30
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	27
Epithelial recognition and elimination against aberrant cells	27
Intracellular galectin interactions in health and disease	25
The contribution of sleep to the neuroendocrine regulation of rhythms in human leukocyte traffic	25
Correction to: MAIT cells in liver inflammation and fibrosis	24
The twilight zone: plasticity and mixed ontogeny of neutrophil and eosinophil granulocyte subsets	24
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	24
Regulatory T lymphocytes as a therapy for ischemic stroke	24
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	22
Genetics and functional genomics of multiple sclerosis	22
Crosstalk between the DNA damage response and cellular senescence drives aging and age-related diseases	22
The role of circulating cell-free DNA as an inflammatory mediator after stroke	22
Functional heterogeneity of CD4+ T cells in liver inflammation	22